First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases

Go back to First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
(NASDAQ: TRAX) Delayed: 17.42 -0.75 (4.13%)
Previous Close $18.17    52 Week High
Open $18.69    52 Week Low
Day High $19.71    P/E N/A 
Day Low $17.06    EPS
Volume 1,915,187